The brain renin-angiotensin system: A target for novel antidepressants and anxiolytics

Drug Development Research

Volumn 65, Issue 4, 2005, Pages 270-277

  Gard, Paul R ^a  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

Author keywords

ACE inhibitors; Anxiety; AT1 receptor antagonists; Depression

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN III; ANGIOTENSIN RECEPTOR; ANGIOTENSINOGEN; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE RECEPTOR; CANDESARTAN; CAPTOPRIL; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUOXETINE; GLUTAMYL AMINOPEPTIDASE; IMIPRAMINE; LOSARTAN; MESSENGER RNA; MIANSERIN; MICROSOMAL AMINOPEPTIDASE; NALOXONE; NEUROTRANSMITTER; RENIN; TRANYLCYPROMINE; UNINDEXED DRUG;

ALLELE; ANXIETY DISORDER; BRAIN; DEPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; HYPOTENSION; MOOD DISORDER; NONHUMAN; RECEPTOR DENSITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; STRESS;

EID: 29544435530     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.20028     Document Type: Review

References (53)

1. Albiston AL, McDowall SG, Matsacos D, Sim P, Clune E, Mustafa T, Lee J, Mendelsohn FAO, Simpson RJ, Connolly LM, Chai SY. 2001. Evidence that the angiotensin IV (AT4) receptor is the enzyme insulin regulated aminopeptidase. J Biol Chem 276:48623-48626.
2. Arinami T, Li LM, Mitsushio H, Itokawa M, Hamaguchi H, Toru M. 1996. An insertion/deletion polymorphism in the angiotensin converting enzyme gene is associated with both brain substance P contents and affective disorders. Biol Psychiatry 40:1122-1127.
3. Arletti R, Bertolini A. 1987. Oxytocin acts as an antidepressant in two animal models of depression. Life Sci 41:1725-1730.
4. 1 receptor antagonist decreases the hypothalamic-pituitary-adrenal response to stress. Endocrinology 142:3880-3889.
5. Barnes NM, Costall B, Kelly ME, Murphy DA, Naylor RJ. 1990. Anxiolytic-like action of DnP753, a non-peptide angiotensin II receptor antagonist. Neuroreport 1:15-16.
6. Braszko JJ, Karwowska-Polecka W, Halicka D, Gard PR. 2003. Captopril and enalapril improve cognition and mood in hypertensive patients. J Basic Clin Physiol Pharmacol 14:323-343.
7. 1 receptor antagonism prevent stress-induced gastric injury. Am J Physiol 285:G414-G423.
8. Camhursano PT, Haigli SJ, Keightley J, Sutcliffe MA, Gard PR. 1997. Positive effects of losartan in laboratory tests indicative of anxiolytic-like activity and the importance of animal strain. J Pharm Pharmacol 49(suppl 4):64.
9. Costall B, Domeney AM, Gerrard PA, Horovitz ZP, Kelly ME, Naylor RJ, Tomkins DM. 1990. Effects of captopril and SQ29,852 on anxiety-related behaviours in rodent and marmoset. Pharmacol Biochem Behav 36:13-20.
10. Costall B, Jones BJ, Kelly ME, Naylor RJ, Tomkins DM. 1989. Exploration of mice in a black and white test box: validation as a model of anxiety. Pharmacol Biochem Behav 32:777-785.
11. Cresswell AG, Gard PR. 1998. Behavioural evidence of a paradoxical anxiogenic effect of an angiotensin II (AT1) receptor antagonist. J Pharm Pharmacol 50(suppl):215.
12. Cryan JF, Valentino RJ, Lucki I. 2005. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29:547-569.
13. Currie D, Lewis RV, McDevitt DC, Nicholson AN, Wright NA. 1990. Central effects of the angiotensin-converting enzyme-inhibitor, captopril. I. Performance and subjective mood. Br J Clin Pharmacol 30:527-536.
14. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. 2000. The angiotensin II receptors. Pharmacol Rev 52:415-472.
15. Deicken RF. 1986. Captopril treatment of depression. Biol Psychiatry 21:1425-1428.
16. Furlong RA, Kennnatipour M, Ho LW, Rubinsztein JS, Michael A, Walsli C, Paykel ES, Rubinsztein DC. 2000. No association of an insertion/deletion polymorphism in the angiotensin 1 converting enzyme gene with bipolar or unipolar affective disorders. Am J Med Genet 96:733-735.
17. Gard PR. 2002. The role of angiotensin in cognition and behaviour. Eur J Pharmacol 438:1-14.
18. Gard PR, Barnes NM. 1994. The effects of desipramine and fluoxetine on responses to angiotensin and angiotensin receptors. Can J Physiol Pharmacol 72(suppl 1):439.
19. Gard PR, Haigh SJ, Cambursano PT, Warrington CA. 2001. Strain differences in the anxiolytic effects of losartan in the mouse. Pharmacol Biochem Behav 69:35-40.
20. Gard PR, Mandy A, Sutcliffe MA. 1999. Evidence of a possible role of altered angiotensin function in the treatment, but not aetiology, of depression. Biol Psychiatry 45:1030-1034.
21. Gard PR, Mandy A, Whiting JM, Nickels DPD, Meakin AJLS. 1994. Reduction of responses to angiotensin II by antidepressant drugs. Eur J Pharmacol 264:295-300.
22. Gard PH, Mycroft N. 1991. Reduction of angiotensin II-induced drinking in rats by 21 hour pretreatment with desipramine. J Pharm Pharmacol 43(suppl):1.
23. Gard PR, Yeoman MS, Saab Y. 2005. Polymorphisms of the renin-angiotensin system: association with depressive illness in a Lebanese population. Br J Clin Pharmacol 59:640-641.
24. Garrean I, Chansel D, Vandermeersch S, Fruitier I, Piot J-M, Ardaillon R. 1998. Hemorphins inhibit angiotensin IV binding and interact with aminopeptidase N. Peptides 19:1339-1348.
25. Georgiev V, Getova D, Opitz M. 1987. Mechanisms of the angiotensin II effects on the exploratory behaviour of rats in open field. I. Interaction of angiotensin II with saralasin and catecholamine drugs. Find Exp Clin Pharmacol 9:297-301.
26. Germain L, Chouinard G. 1988. Treatment of recurrent unipolar major depression with captopril. Biol Psychiatry 23:637-641.
27. Germain L, Chouinard G. 1989. Captopril treatment of major depression with serial measurements of blood cortisol concentrations. Biol Psychiatry 25:489-493.
28. Ghazi N, Grove KL, Wright JW, Phillips MI, Speth RC. 1994. Variations in angiotensin-II release from the rat brain during the oestrons cycle. Endocrinology 135:1945-1950.
29. Gardina WJ, Ebert DM. 1989. Positive effects of captopril in the behavionral despair swim test. Biol Psychiatry 25:697-702.
30. Kaiser FC, Palmer GC, Wallace AV, Carr RD, Fraserrae L, Hallani C. 1992. Antianxiety properties of the angiotensin-II antagonist, DnP753, in the rat using the elevated plus-maxe. Neuroreport 3:922-924.
31. Martin P, Massol J, Pnech AJ. 1990. Captopril as an antidepressant? Effects on the learned helplessness paradigm in rats. Biol Psychiatry 27:968-974.
32. McDevitt DG, Currie D, Nicholson AN, Wright AN, Zetlein MB. 1994. Central effects of repeated administration of atenolol and captopril in healthy-volunteers. Eur J Clin Pharmacol 46:23-28.
33. Mendelsohn FAO, Allen AM, Chai S-Y, McKinley MJ, Oldfield BJ, Paxinos G. 1990. The brain angiotensin system-insights from mapping its components. Trends Endocrin Met 1:189-198.
34. Meira-Lima IV, Pereira AC, Mota GFA, Krieger JK, Vallada H. 2000. Angiotensinogen and angiotensin converting enzyme gene polymorphisms and the risk of bipolar affective disorders in humans. Neurosci Lett 293:103-106.
35. Nakamura A, Johns EJ. 1995. Renal nerves, renin, and angiotensinogen-gene expression in spontaneously hypertensive rats. Hypertension 25:581-586.
36. Nakamura T, Matsui K, Ito M, Yoshimura T, Kawasaki N, Fujisaki N, Okamura H. 1988. Effects of pregnancy and hormone treatments on pressor response to angiotensin II in conscious rats. Am J Obstet Gynecol 159:989-994.
37. Nicholson AN, Roberts DP, Stone BM, Turner C. 2001. Hypertensive therapy in critical occupations: studies with an angiotensin II antagonist. Aviat Space Environ Med 72:1096-1101.
38. 1 receptors. Brain Res 871:29-38.
39. Okuyama S, Sakagawa T, Chaki S, Imagawa Y, Ichiki T, Inagami T. 1999. Anxiety-like behaviour in mice lacking the angiotensin II type-2 receptor. Brain Res 821:150-159.
40. Pauls J, Bandelow B, Ruther E, Kornhuber J. 2000. Polymorphism of the gene of angiotensin converting enxyme: lack of association with mood disorder. J Neural Transm 107:1361-1366.
41. Phillips MI. 1987. Functions of angiotensin in the central nervous system. Annu Rev Physiol 49:413-435.
42. 1 receptor antagonists. Regul Pept 128:227-238.
43. Senanayake PD, Moriguchi A, Kumagai H, Ganten D, Ferrario CM, Brosnihan KB. 1994. Increased expression of angiotensin peptides in the brain of transgenic hypertensive rats. Peptides 15:919-926.
44. Shepherd J, Bill DJ, Donrish CT, Grewal SS, McLenachan A, Stanhope KJ. 1996. Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory. Psychopharmacology (Berl) 126:206-218.
45. Tsuda A, Tanaka M, Georgiev V, Emoto H. 1992. Effects of angiotensin II on behavioral responses of defensive burying paradigm in rats. Pharmacol Biochem Behav 43:729-732.
46. Vauquelin G, Michotte Y, Smolders I, Sarre S, Ebinger G, Dupont A, Vanderheyden P. 2002. Cellular targets for angiotensin II fragments: pharmacological and molecular evidence. J RAAS 3:195-204.
47. Voigt JP, Hortnagl H, Hex A, van Hove L, Bader M, Fink H. 2005. Brain angiotensinogen and anxiety-related behavior: the transgenic rat TGR(ASrAOGEN)680. Brain Res 1046:145-156.
48. Voigt JP, Rex A, Bader M, Fink H. 2000. From genotype to phenotype-behaviour of the transgenic rat TGR (mRen2)27 as an example. Rev Neurosci 11:37-45.
49. Voigt JP, Rex A, Sohr R, Fink H. 1999 Hippocampal 5-HT and NE release in the transgenic rat TGR(mREN2)27 related to behaviour on the elevated plus maze. Eur Neuropsychopharmacol 9:279-285.
50. Walther T, Voigt J-P, Fukamizu A, Fink H, Bader M. 1999. Learning and anxiety in angiotensin-deficient mice. Behav Brain Res 100:1-4.
51. Wilson W, Voigt J P, Bader M, Marsden CA, Fink H. 1996. Behaviour of the transgenic (mREN2) 27 rat. Brain Res 729:1-9.
52. Wright JW, Harding JW. 1997. Important roles for angiotensin III and IV in the brain renin-angiotensin system. Brain Res Rev 25:96-124.
53. Zubenko GS, Nixon RA. 1984. Mood-elevating effect of captopril in depressed patients. Am J Psychiatry 141:110-111.